Position in RVMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$196,272,061
+$46,073,715 QoQ
Shares Held
1,048,014
-32.1% QoQ
Ownership
0.489%
of shares outstanding
% of Portfolio
4.25%
of 13F equity value
Holder Rank
#38
of 685 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. RVMD ranks #3 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
578,634 | $287,424,866 | |
| 2 | ARGX |
Argenx SE
|
301,000 | $279,258,770 | |
| 3 | RVMD |
Revolution Medicines, Inc.
This page
|
1,048,014 | $196,272,061 | |
| 4 | ORKA |
Oruka Therapeutics, Inc.
|
1,657,190 | $157,714,772 | |
| 5 | INSM |
INSMED Inc
|
1,393,418 | $148,566,226 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
2,449,547 | $134,725,085 | |
| 7 | VRDN |
Viridian Therapeutics, Inc.\DE
|
6,731,909 | $123,665,167 | |
| 8 | RLAY |
Relay Therapeutics, Inc.
|
6,185,970 | $115,739,498 |
All Filings in RVMD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $196,272,061 | 1,048,014 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $150,198,346 | 1,544,456 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $398,705,518 | 5,005,719 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $260,298,234 | 5,573,838 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $168,472,447 | 4,579,300 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $154,675,248 | 4,374,300 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $191,883,006 | 4,386,900 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $220,916,176 | 4,871,360 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $195,179,371 | 5,029,100 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $163,522,128 | 5,073,600 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $146,009,880 | 5,091,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $130,691,120 | 4,721,500 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $126,955,500 | 4,746,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $102,839,514 | 4,747,900 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $115,649,958 | 4,855,162 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $92,292,794 | 4,680,162 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $65,939,776 | 3,383,262 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $84,454,987 | 3,310,662 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $87,343,977 | 3,470,162 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $95,151,725 | 3,458,805 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $58,871,510 | 1,854,805 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $48,897,527 | 1,065,770 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,583,600 | 40,000 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||